Details
Stereochemistry | ACHIRAL |
Molecular Formula | C7H10NO6P2.Na |
Molecular Weight | 289.0947 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].OP(O)(=O)C(CC1=CC=CC=N1)P(O)([O-])=O
InChI
InChIKey=LZNFXJFOLTVFOP-UHFFFAOYSA-M
InChI=1S/C7H11NO6P2.Na/c9-15(10,11)7(16(12,13)14)5-6-3-1-2-4-8-6;/h1-4,7H,5H2,(H2,9,10,11)(H2,12,13,14);/q;+1/p-1
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C7H10NO6P2 |
Molecular Weight | 266.1049 |
Charge | -1 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Piridronic acid is pyridinyl bisphosphonate. It is the bone calcium metabolism regulator. Piridronic acid was used for the treatment of osteoporosis. It is the human farnesyl pyrophosphate synthase inhibitor. When expressed on an actual or anticipated clinical dose basis for osteoporosis piridronic acid may have a greater potential for inducing gastric damage than do pyridinyl bisphosphonates. Piridronic acid induced significantly more antral damage than risedronate and a greater number of lesions compared to pamidronate and risedronate.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:45:24 GMT 2023
by
admin
on
Fri Dec 15 17:45:24 GMT 2023
|
Record UNII |
977W2XFR3R
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL99369
Created by
admin on Fri Dec 15 17:45:24 GMT 2023 , Edited by admin on Fri Dec 15 17:45:24 GMT 2023
|
PRIMARY | |||
|
Y-24
Created by
admin on Fri Dec 15 17:45:24 GMT 2023 , Edited by admin on Fri Dec 15 17:45:24 GMT 2023
|
PRIMARY | |||
|
C175191
Created by
admin on Fri Dec 15 17:45:24 GMT 2023 , Edited by admin on Fri Dec 15 17:45:24 GMT 2023
|
PRIMARY | |||
|
100188-33-8
Created by
admin on Fri Dec 15 17:45:24 GMT 2023 , Edited by admin on Fri Dec 15 17:45:24 GMT 2023
|
PRIMARY | |||
|
DTXSID40905247
Created by
admin on Fri Dec 15 17:45:24 GMT 2023 , Edited by admin on Fri Dec 15 17:45:24 GMT 2023
|
PRIMARY | |||
|
23700062
Created by
admin on Fri Dec 15 17:45:24 GMT 2023 , Edited by admin on Fri Dec 15 17:45:24 GMT 2023
|
PRIMARY | |||
|
C054229
Created by
admin on Fri Dec 15 17:45:24 GMT 2023 , Edited by admin on Fri Dec 15 17:45:24 GMT 2023
|
PRIMARY | |||
|
977W2XFR3R
Created by
admin on Fri Dec 15 17:45:24 GMT 2023 , Edited by admin on Fri Dec 15 17:45:24 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |